Clinical Significance of Anti-U1 Ribonucleoprotein Antibody in Anti-Topoisomerase I Antibody-Positive Systemic Sclerosis Patients: A Retrospective Observational Study. acbr. 2021;5(1):76-84. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/14819